Tretinoin Telehealth Pricing

Direct answer

RightFit now tracks standalone telehealth tretinoin cream pricing from Nurx, 10Rx, and TRAVA, plus tretinoin-containing combination products from Musely, Apostrophe, Curology, and Winona. Those products use different billing models and formulations: some are standalone tretinoin creams, while others combine tretinoin with ingredients such as niacinamide, dexpanthenol, estriol, or other customized actives. RightFit keeps those combination products separate from standalone tretinoin pricing.

Current tracked tretinoin market snapshot

10Rx uses a quarterly pricing model

10Rx’s current tretinoin product page lists an effective monthly amount and a quarterly charge due for the plan. The page states that medication, provider evaluation, and delivery are included. RightFit therefore keeps the effective monthly amount tied to the quarterly billing structure instead of presenting it as a standalone month-to-month purchase.

10Rx’s broader pricing page also explains that its medication packages use quarterly pricing and include consultation, shipping, and ongoing support without separate add-on fees. The product-specific tretinoin page is the stronger source for the actual current tretinoin amount.

TRAVA publishes a monthly price with multiple cream strengths

TRAVA’s current tretinoin page lists a monthly price and multiple cream strengths, including 0.025%, 0.05%, and 0.1% options in different tube sizes. The page also states that the price can change if the prescribed strength changes. RightFit therefore treats the displayed amount as a current provider price with strength-dependent context rather than a guarantee that every strength costs the same.

TRAVA’s current product page also states that shipping and handling are included at no additional cost. RightFit records that inclusion separately from the medication amount so future changes to shipping policy or product price can be tracked independently.

The official tretinoin cream label provides a regulatory reference

Current official tretinoin cream labeling lists topical tretinoin for acne vulgaris and includes 0.025%, 0.05%, and 0.1% cream strengths. RightFit uses the official label to establish approved-product context while using the provider pages for telehealth pricing, services, and available commercial options.

Provider skincare claims and the official indication are not the same thing

Telehealth product pages can market tretinoin around acne, texture, skin renewal, uneven tone, or visible signs of aging. RightFit can describe those provider claims when relevant, but the official cream label is the stronger source for the labeled indication. Provider marketing should not silently expand the approved indication in the editorial copy.

Strength belongs beside the price

Tretinoin cream can be available in multiple strengths, and providers can price those strengths differently. TRAVA explicitly says its pricing can change when the prescribed strength changes. A market comparison should therefore not use the lowest or default displayed amount as the universal price for every strength unless the provider’s own terms establish flat pricing.

Billing cadence changes what a monthly number means

10Rx demonstrates why RightFit distinguishes a monthly equivalent from monthly billing. The product page displays a per-month figure but charges the quarterly total for the plan. TRAVA, by contrast, currently describes a monthly plan structure. Those two figures can be normalized for comparison while the underlying billing cadence stays visible.

Included services can explain part of the price difference

10Rx explicitly includes provider evaluation and delivery in the current tretinoin package. TRAVA’s current page includes shipping and operates inside a telehealth care pathway with provider review. RightFit records those service inclusions rather than assuming the displayed price is medication-only.

Provider price and pharmacy cash price are different comparisons

Tretinoin cream can also be obtained through ordinary prescription pharmacy channels outside the telehealth programs tracked here. RightFit’s page therefore compares verified telehealth program prices, not the universal retail cash price of tretinoin. A pharmacy-only price and a provider program that includes evaluation and delivery do not necessarily purchase the same services.

Preparation type should not be guessed

The current RightFit formulation records do not automatically label every tretinoin cream as compounded or manufactured unless the source supports that distinction. RightFit therefore avoids assigning preparation type from branding or tube appearance and focuses on the verified formulation, route, strength, and provider terms.

State availability needs program-level evidence

A telehealth provider’s general footprint does not prove that tretinoin can be prescribed and fulfilled in every state. Clinician licensure, pharmacy coverage, and provider policy can affect access. RightFit only publishes state availability where the applicable provider source supports it.

What to compare across tretinoin telehealth programs

• Topical cream formulation and available strengths.
• Current provider-displayed price.
• Whether pricing changes with strength.
• Billing period and supply term.
• Whether the displayed amount is a monthly charge or a monthly equivalent.
• Whether provider evaluation is included.
• Whether shipping or delivery is included.
• Program-level state availability when verified.
• Provider-primary source and last-verification date.
• Official product labeling kept separate from provider marketing claims.

What RightFit will not infer

• The lowest displayed strength price is not treated as the price of every strength.
• A quarterly monthly-equivalent amount is not treated as true month-to-month billing.
• A provider claim about wrinkles, texture, or photoaging is not automatically treated as the labeled indication.
• Preparation type is not guessed when the source does not make it clear.
• A lower telehealth price does not establish better clinical value.
• A provider product page does not determine which strength is appropriate for an individual.
• General provider availability is not treated as nationwide product availability without evidence.

Why the old price-unknown statement needed correction

The prior RightFit draft correctly followed a conservative rule when 10Rx had no sufficiently verified product-specific price. The current dedicated 10Rx page now supplies the missing commercial evidence, including the effective monthly amount, quarterly total, and included services. The right response is to update the record rather than preserve the older unknown state after the source improves.

This is how the verification model should work

A provider can move from unknown to published pricing when a current first-party source becomes sufficiently clear. The reverse is also possible if a page later becomes contradictory. RightFit’s status should follow the evidence rather than remaining permanently tied to the first observation.

Why source freshness matters

Skincare providers can change strengths, tube sizes, billing terms, bundled services, or promotional pricing without changing the treatment name. RightFit favors the current dedicated product page and maintains verification dates so a stale price does not survive simply because the product is still called tretinoin.

Questions a reader can use

• What strength and tube size does the displayed price cover?
• Can the price change with strength?
• Is the amount billed monthly or quarterly?
• Are provider evaluation and delivery included?
• Is the product available in my state?
• Is the provider making claims beyond the official labeled indication?
• Is the source a current dedicated product page?
• When was the price last verified?

What this comparison cannot decide

A public pricing comparison cannot determine whether tretinoin is appropriate for an individual, which strength is appropriate, how often it should be used, or how it should be combined with other skincare products. Those are individualized clinical questions. RightFit limits the page to product, price, program, and regulatory information.

Bottom line

RightFit’s tretinoin coverage now includes standalone programs from Nurx, 10Rx, and TRAVA plus clearly labeled combination formulas from Musely, Apostrophe, Curology, and Winona. Nurx publishes $30 per month effective, 10Rx $38.99 per month effective, and TRAVA currently displays $102.71 per month; combination products are tracked under their exact formulas rather than folded into a misleading standalone tretinoin price.

Nurx adds another standalone tretinoin benchmark

Nurx currently publishes tretinoin cream in 0.025%, 0.05%, and 0.1% strengths at $30 per month, with $90 charged for a three-month supply. Nurx also charges a $3 support fee in months when eligible skin or hair orders are processed, and its medical-consultation fee can vary by dermatology care path. RightFit therefore keeps the medication price, supply term, and separate fees distinct.

Musely should be compared as a tretinoin-containing combination, not standalone tretinoin

Musely’s current Anti-Aging Cream is $35 per month and uses customized tretinoin strengths of 0.025%, 0.05%, or 0.1% with niacinamide and hyaluronic acid. Musely also charges a $20 first-order or new-treatment doctor visit. Because this is a multi-ingredient customized formula, RightFit stores it separately rather than placing its price in the standalone tretinoin table.